Biotest Aktiengesellschaft (BIO) — Net Asset Quality Index
Biotest Aktiengesellschaft (BIO) has a Net Asset Quality Index of 36.0% as of March 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.42 Billion minus total liabilities of €906.90 Million yields net assets of €509.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Biotest Aktiengesellschaft liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biotest Aktiengesellschaft Net Asset Quality Index Over Time (2002–2024)
This chart shows how Biotest Aktiengesellschaft's Net Asset Quality Index has evolved across 23 annual periods from 2002 to 2024. As of March 2025, the index stands at 36.0%, representing net assets of €509.60 Million against total assets of €1.42 Billion EUR. See BIO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Biotest Aktiengesellschaft (2002–2024)
The table below presents the year-by-year Net Asset Quality Index for Biotest Aktiengesellschaft from 2002 to 2024, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Biotest Aktiengesellschaft (BIO) market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 37.0% | €530.70 Million | €1.43 Billion | €903.30 Million | ▲ +1.6 pp |
| 2023 | 35.4% | €498.90 Million | €1.41 Billion | €912.00 Million | ▲ +4.5 pp |
| 2022 | 30.8% | €371.10 Million | €1.20 Billion | €831.90 Million | ▼ -3.6 pp |
| 2021 | 34.5% | €380.40 Million | €1.10 Billion | €723.80 Million | ▼ -4.6 pp |
| 2020 | 39.0% | €441.60 Million | €1.13 Billion | €689.70 Million | ▼ -4.0 pp |
| 2019 | 43.0% | €476.90 Million | €1.11 Billion | €631.50 Million | ▼ -4.5 pp |
| 2018 | 47.5% | €495.20 Million | €1.04 Billion | €547.10 Million | ▲ +12.0 pp |
| 2017 | 35.5% | €347.80 Million | €978.50 Million | €630.70 Million | ▼ -3.1 pp |
| 2016 | 38.7% | €360.70 Million | €932.80 Million | €572.10 Million | ▼ -4.2 pp |
| 2015 | 42.8% | €412.30 Million | €962.70 Million | €550.40 Million | ▼ -3.7 pp |
| 2014 | 46.5% | €480.20 Million | €1.03 Billion | €552.40 Million | ▼ -5.5 pp |
| 2013 | 52.0% | €460.70 Million | €886.50 Million | €425.80 Million | ▼ -2.2 pp |
| 2012 | 54.1% | €369.43 Million | €682.35 Million | €312.91 Million | ▲ +3.4 pp |
| 2011 | 50.8% | €346.67 Million | €682.76 Million | €336.09 Million | ▲ +2.1 pp |
| 2010 | 48.6% | €307.61 Million | €632.34 Million | €324.73 Million | ▲ +6.0 pp |
| 2009 | 42.6% | €269.86 Million | €633.45 Million | €363.59 Million | ▼ -0.2 pp |
| 2008 | 42.8% | €253.37 Million | €592.04 Million | €338.67 Million | ▲ +0.7 pp |
| 2007 | 42.1% | €225.76 Million | €536.70 Million | €310.94 Million | ▼ -5.9 pp |
| 2006 | 47.9% | €179.31 Million | €374.01 Million | €194.69 Million | ▲ +1.9 pp |
| 2005 | 46.0% | €168.97 Million | €367.09 Million | €198.12 Million | ▲ +15.9 pp |
| 2004 | 30.1% | €107.97 Million | €358.27 Million | €250.31 Million | ▲ +0.6 pp |
| 2003 | 29.5% | €103.29 Million | €349.98 Million | €246.69 Million | ▼ -0.3 pp |
| 2002 | 29.8% | €110.79 Million | €371.99 Million | €261.20 Million | — |